The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy

Published:2021-09 Issue: Volume:Volume 14 Page:4433-4444
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Topkan Erkan^ORCID,Selek Ugur^ORCID,Pehlivan Berrin,Kucuk Ahmet,Haksoyler Veysel^ORCID,Kilic Durankus Nulifer,Sezen Duygu^ORCID,Bolukbasi Yasemin

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Pancreatic Cancer

2. Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review

3. Locally Advanced Pancreatic Cancer: A Review

4. Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis;Journal of Personalized Medicine;2024-07-13

2. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up;Hepatobiliary Surgery and Nutrition;2024-02

3. Prognostic significance of the systemic inflammation response index in gastrointestinal malignancy patients: a pooled analysis of 10,091 participants;Future Oncology;2023-09

4. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression;Journal of Evidence-Based Integrative Medicine;2023-01

5. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas;Journal of Inflammation Research;2022-09